What you'll learn
- Biological therapies for IBD: how to choose which agent to start with? How to monitor during treatment? What is the role for therapeutic drug monitoring? When to switch? What new agents are now available?
- Managing refractory pouchitis
- GI complications of immunotherapy — a common and heterogeneous disorder: how to approach and treat effectively?
- Antiviral therapies for hepatitis B and C: how to select which regimen to use? Understanding long-term risks of therapy
- See the course registration details for additional topics
Course description
This is an accredited, livestreamed course offered by Massachusetts General Hospital, Brigham Health, and Beth Israel Deaconess Medical Center. This course is targeted to Gastroenterologists, Internists, Surgeons, Nurse Practitioners, Physician Assistants.
Select the Take Course button to view additional information on the course registration page.
Contact ceprograms@hms.harvard.edu with questions.
Associated Schools
Harvard Medical School
Enroll now.
Take courseYou may also like
This course will focus on adult DVT patients with an emphasis upon testing, anticoagulant therapy, and inherited thrombophilia.$49Register byJun 17- Review research studies and advancements in topics including bipolar depression, psychopharmacology, comorbid illnesses, and...$149Register byJul 7
- This course will advance your knowledge of interpreting state-of-the-art electrocardiograms.$299Register byJul 21
